An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer

Cancer Research

Volumn 58, Issue 5, 1998, Pages 863-866

  Savelyeva, Larissa ^a   Claas, Andreas ^a   Gier, Simone ^a   Schlag, Peter ^b   Finke, Lothar ^b   Mangion, Jonathan ^c   Stratton, Michael R ^c   Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME DUPLICATION; CHROMOSOME INSERTION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

BRCA2 PROTEIN; BREAST NEOPLASMS, MALE; CHROMOSOMES, HUMAN, PAIR 9; DNA TRANSPOSABLE ELEMENTS; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; NEOPLASM PROTEINS; PEDIGREE; TRANSCRIPTION FACTORS;

EID: 0032031074     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schottenfeld, D., Lilienfeld, A. M., and Diamond, H. Some observations on the epidemiology of breast cancer among males. Am. J. Publ. Health, 53: 890-897, 1963.
2. Schön, M., Zaiac, M., and Schlag, P. M. Male breast cancer. Onkologie, 18: 16-21, 1995.
3. Wagner, J. L., Thomas, C. R., Koh, W-J., and Rudolph, R. H. Carcinoma of the male breast: update 1994. Med. Pediatr. Oncol., 24: 123-132, 1995.
4. Rose, D. P. Endocrine epidemiology of male breast cancer. Anticancer Res., 8: 45-850, 1988.
5. Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., and Stratton, M. R. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat. Genet., 2: 132-134, 1992.
6. Lobaccaro, J-M., Lumbroso, S., Belon, C., Galtier-Dereure, F., Bringer, J., Lesimple, T., Namer, M., Cutuli, F., Pujoi, H., and Sultan, C. Androgen receptor gene mutation in male breast cancer. Hum. Mol. Genet., 2: 1799-1802, 1993.
7. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ormiston, W., McManus, R., Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A. J., Skolnick, M. H., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington DC), 265: 2088-2090, 1994.
8. Thorlacius, S., Tryggvardottir, L., Olafsdottir, G. H., Jonasson, J. G., Ogmundsdottir, H. M., Tulinius, H., and Eyfjord, J. E. Linkage to BRCA2 region in hereditary male breast cancer. Lancet, 346: 544-545, 1995.
9. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs. P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkadottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R. Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 378: 789-792, 1995.
10. Couch, F. J., Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., Shattuck-Eidens, D., Godwin, A. K., Daly, M., Radford, D. M., Sedlacek, S., Rommens, J., Simard, J., Garber, J., Merajver, S., and Weber, B. L. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet., 13: 123-125, 1996.
11. Phelan, C. M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., Perret, C., Moslehi, R., Dion, F., Faucher, M-C., Dole, K., Karimi, S., Foulkes, W., Lounis, H., Warner, E., Goss, P., Anderson, D., Larsson, C., Narod, S. A., and Futreal, P. A. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet., 13: 120-122, 1996.
12. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J-F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, B., Swensen, J., Teng, D., Thomas, A., Tran, T., Tranchant, M., Weaver-Feldhaus, J., Wong, A. K. C., Shizuya, H., Eyfjord, J. E., Cannon-Albright, L., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
13. Thorlacius, S., Olafsdottir, G., Tryggvardottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ogmundsdottir, H. M., and Eyfjord, J. E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet., 13: 117-119, 1996.
14. Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A., and Anton-Culver, H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet., 60: 313-319, 1997.
15. Gayther, S. A., Mangion, J., Russel, P., Seal, S., Barfoot, R., Ponder, B. A., Stratton, M. R., and Easton, D. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet., 15: 103-105, 1997.
16. Hakansson, S., Johansson, O., Johansson, U., Sellberg, G., Loman, N., Gerdes, A-M., Holmberg, E., Dahl, N., Pandis, N., Kristoffersson, U., Olsson, H., and Borg, A. Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet., 60: 1068-1078, 1997.
17. Schubert, E. L., Lee, M. K., Mefford, H. C., Argonza, R. H., Morrow, J. E., Hull, J., Dann, J. L., and King, M-C. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance and the possibility of families whose breast cancer is not attributable to BRCA1 or BRCA2. Am. J. Hum. Genet., 60: 1031-1040, 1997.
18. Serova, O. M., Mazoyer, S., Puget, N., Dubois, V., Tonin, P., Shugart, Y. Y., Goldgar, D., Narod, S. A., Lynch, H. T., and Lenoir, G. M. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes. Am. J. Hum. Genet., 60: 486-595, 1997.
19. Thorlacius, S., Sigurdsson, S., Bjarnadottir, H., Olafsdottir, G., Jonasson, J. G., Tryggvardottir, L., Tulinius, H., and Eyfjord, J. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet., 60: 1079-1084, 1997.
20. Savelyeva, L., Corvi, R., and Schwab, M. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am. J. Hum. Genet., 55: 334-340, 1994.
21. Corvi, R., Amler, L. C., Savelyeva, L., Gehring, M., and Schwab, M. MYCN is retained in single copy at chromosome band 2p23-24 during amplification in human neuroblastoma cells. Proc. Natl. Acad. Sci. USA, 91: 5523-5527, 1994.
22. de la Chapelle, A., Schröder, J., Stensand, K., Fellman, J., Herva, R., Saarni, M., Auttolainen, I., Tallila, L., Tervilae, L., Husa, L., Tallquist, G., Robson, E. B., Cook, P. J. L., and Sanger, R. Pericentric inversion of human chromosomes 9 and 10. Am. J. Hum. Genet., 26: 746-765, 1974.
23. Berger, R., Bernheim, A., Kristoffersson, U., Mitelman, F., and Olsson, H. C-band heteromorphism in breast cancer patients. Cancer Genet. Cytogenet., 18: 37-42, 1985.
24. Suciu, S. Constitutive heterochromatin studies in patients with solid tumors. J. Cancer Res. Clin. Oncol., 111: 291-294, 1986.
25. Wang, J-C. C., and Miller, W. A. Molecular cytogenetic characterization of two types of chromosome 9 variants. Cytogenet. Cell Genet., 67: 190-192, 1994.
26. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.